Stocks Under Scanner in the Medical Research Space -- Organovo, BioTelemetry, Bruker, and PerkinElmer

Tuesday, October 10, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, October 10, 2017 /PRNewswire/ --

If you want a Stock Review on ONVO, BEAT, BRKR, or PKI then come over

to and sign up for your free customized report. On Monday, October 09, 2017, the NASDAQ Composite ended the trading session at 6,579.73, down 0.16%; the Dow Jones Industrial Average
edged 0.06% lower, to finish at 22,761.07; and the S&P 500 closed at 2,544.73, slightly dropping 0.18%. US markets saw five out of nine sectors finishing the day in red, two in green, and two in neutral territory. This Tuesday, has initiated reports coverage on the following Medical Laboratories & Research equities: Organovo Holdings Inc. (NASDAQ: ONVO), BioTelemetry Inc. (NASDAQ: BEAT), Bruker Corp. (NASDAQ: BRKR), and PerkinElmer Inc. (NYSE: PKI). Take a look at the free research reports issued today on for these stocks by signing up at:

Organovo Holdings 

San Diego, California headquartered Organovo Holdings Inc.'s stock finished Monday's session 4.41% lower at $1.95. A total volume of 924,587 shares was traded, which is above its three months average volume of 825.91 thousand shares. The stock is trading below its 50-day moving average by 6.82%. Additionally, shares of Organovo, which designs and creates functional and three-dimensional human tissues for use in medical research and therapeutic applications, have a Relative Strength Index (RSI) of 40.50. Sign up and read the free research report on ONVO at:


On Monday, shares in Malvern, Pennsylvania headquartered BioTelemetry Inc. recorded a trading volume of 409,004 shares. The stock ended the session 0.45% higher at $33.35. The Company's shares have advanced 65.10% over the last twelve months and 49.22% on an YTD basis. The stock is trading above its 200-day moving average by 12.57%. Moreover, shares of BioTelemetry, which provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services, have an RSI of 48.26. The complimentary research report on BEAT can be downloaded at:


Billerica, Massachusetts headquartered Bruker Corp.'s shares closed the day 0.30% lower at $30.32. The stock recorded a trading volume of 285,763 shares. The Company's shares have gained 35.42% over the last twelve months and 43.15% since the start of the year. The stock is trading above its 50-day and 200-day moving averages by 4.95% and 16.77%, respectively. Additionally, shares of Bruker, which develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide, have an RSI of 65.78.

On September 26th, 2017, research firm Goldman resumed its 'Sell' rating on the Company's stock, with a target price of $24 per share. Register for free on and access the latest report on BRKR at:


Shares in Waltham, Massachusetts headquartered PerkinElmer Inc. finished 0.01% higher at $70.62. The stock recorded a trading volume of 1.14 million shares, which is above its three months average volume of 601.27 thousand. The Company's shares have advanced 26.79% over the last twelve months and 35.42% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 5.62% and 15.40%, respectively. Furthermore, shares of PerkinElmer, which provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide, have an RSI of 78.24.

On September 26th, 2017, research firm Goldman resumed its 'Neutral' rating on the Company's stock, with a target price of $67 per share. Get free access to your research report on PKI at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit:

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store